Similarly, metformin has been shown to impede TGF-β-promoted loss of the epithelial marker E-cadherin in MCF-7 breast cancer cells (11), and to prevent accumulation of the mesenchymal marker vimentin in Madin-Darby canine kidney cells [11, 12]. Here, CDH1 is linked to breast cancer.